title: Enteral ecoimmunonutrition reduced enteral permeability and serum ghrelin activity in severe cerebral stroke patients with lung infection.
abstract: The study analyzed how enteral ecoimmunonutrition, which comprises probiotics, glutamine, fish oil, and Enteral Nutritional Suspension (TPF), can impact on the enteral permeability and serum Ghrelin activity in severe cerebral stroke patients with lung infection. Among 190 severe cerebral stroke patients with tolerance to TPF, they were randomized into control and treatment groups after antibiotics treatment due to lung infections. There were 92 patients in the control group and 98 patients in treatment group. The control group was treated with TPF and the treatment group was treated with enteral ecoimmunonutrition, which comprises probiotics, glutamine, fish oil, and Enteral Nutritional Suspension. All patients received continuous treatments through nasoenteral or nasogastric tubes. 7, 14, and 21 days after the treatments, the enteral tolerance to nutrition was observed in both groups. The tests included abdominal pain, bloating, diarrhea, and lactulose/mannitol (L/M) ratio. Serum Ghrelin levels were determined by ELISA. The incidence of abdominal pain, bloating, diarrhea was lower in the treatment group and enteral tolerance to nutrition was also superior to the control group. No difference in serum Ghrelin level was observed between the control and treatment groups with enteral intolerance to nutrition. However, in patients with enteral tolerance to nutrition, the treatment group showed lower enteral nutrition and lower enteral permeability compared to the control group. In severe cerebral stroke patients with lung infection, enteral ecoimmunonutrition after antibiotics treatment improved enteral tolerance to nutrition and reduced enteral permeability; meanwhile, it lowered the serum Ghrelin activity, which implied the high serum Ghrelin reduces enteral permeability.
authors.affiliation: Department of Neurology, Liaocheng People's Hospital, Liaocheng, 252000, Shandong, China, xiaodixuzq@163.com.
authors.forename: Xiao-Di
authors.initials: XD
authors.lastname: Xu
authors.forename: Feng
authors.initials: F
authors.lastname: Shao
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000368:Aged; D001424:Bacterial Infections / Q000150:complications*; D004750:Enteral Nutrition / Q000009:adverse effects; D005260:Female; D054439:Ghrelin / Q000097:blood*; D006801:Humans; D007792:Lactulose / Q000652:urine; D008171:Lung Diseases / Q000150:complications*; D008297:Male; D008353:Mannitol / Q000652:urine; D008875:Middle Aged; D010539:Permeability; D020521:Stroke / Q000097:blood / Q000150:complications* / Q000628:therapy* / Q000652:urine; D016896:Treatment Outcome
chemical_list: D054439:Ghrelin; D008353:Mannitol; D007792:Lactulose